Expert Interview
Discussing the 3 year data presented at EULAR 2025 on UCB's BIMZELX (bimekizumab-bkzx) Three-Year Data in Psoriatic Arthritis and Axial Spondyloarthritis
Ticker(s): UCBInstitution: IUHP Rheumatology
- Rheumatologist at IUHP Rheumatology (Indiana) with over 40 years of experience.
- Manages 75 patients with psoriatic arthritis and 20 patients with Axial Spondyloarthritis,
- Special clinical interest is in rheumatoid arthritis
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
